
  
    
      
        Background_NNP
        Phorbol_NNP esters_NNS are_VBP often_RB used_VBN as_IN activators_NNS of_IN protein_NN
        kinase_NN C_NNP (_( PKC_NNP )_) to_TO investigate_VB the_DT role_NN of_IN the_DT kinase_NN in_IN
        cellular_JJ functions_NNS [_NN 1_CD ]_NN ._. Pancreatic_NNP β-cells_JJ possess_VBP α_NN ,_,
        β_NN 1_CD ,_, δ_NN and_CC ε_NN PKC_NNP isotypes_NNS [_NN 2_CD ]_NN ,_, and_CC activation_NN of_IN PKC_NNP is_VBZ
        known_VBN to_TO synergize_NN with_IN glucose_NN stimulation_NN in_IN insulin_NN
        secretion_NN [_NN 3_CD 4_CD 5_CD ]_NN ._. PKC_NNP ,_, via_IN protein_NN phosphorylation_NN
        seems_VBZ to_TO facilitate_VB exocytosis_NNS of_IN insulin_NN granules_NNS [_NN 6_CD 7_CD 8_CD
        ]_NN ._. In_IN glucose-stimulated_JJ insulin_NN secretion_NN ,_, ATP-sensitive_NNP
        K_NNP +_NN channels_NNS (_( K_NNP 
        ATP_NNP (_( SUR_NNP 1_CD ,_, Kir_NNP 6_CD ._. 2_LS )_) )_) play_VB a_DT crucial_JJ role_NN
        [_NN 9_CD 10_CD ]_NN ._. ATP_NNP produced_VBN by_IN the_DT metabolism_NN of_IN glucose_NN
        inhibits_NNS K_NNP 
        ATP_NNP activity_NN ,_, resulting_VBG in_IN development_NN
        of_IN depolarization_NN responsible_JJ for_IN opening_NN of_IN L-_NNP type_NN Ca_MD
        2_CD +_NN channels_NNS ,_, allowing_VBG Ca_MD 2_CD +_NN influx_NN ._. Elevation_NNP of_IN
        intracellular_NN Ca_MD 2_CD +_NN (_( [_NN Ca_MD 2_CD +_NN ]_NN 
        i_NNP )_) accelerates_VBZ exocytosis_NNS of_IN insulin_NN
        granules_NNS ._. The_DT possibility_NN that_IN K_NNP 
        ATP_NNP activity_NN is_VBZ regulated_VBN by_IN PKC_NNP has_VBZ
        long_RB been_VBN studied_VBN ._. In_IN this_DT respect_NN ,_, however_RB ,_, contradictory_JJ
        results_NNS have_VBP been_VBN obtained_VBN ._. For_IN example_NN ,_, in_IN
        insulin-secreting_JJ cell_NN lines_NNS ,_, PKC_NNP was_VBD reported_VBN to_TO
        potentiate_NN K_NNP 
        ATP_NNP activity_NN [_NN 11_CD 12_CD ]_NN ,_, although_IN
        PKC-dependent_NNP inhibition_NN [_NN 13_CD ]_NN or_CC inhibition_NN followed_VBN by_IN
        activation_NN [_NN 14_CD ]_NN has_VBZ been_VBN also_RB reported_VBN ._. In_IN primary_JJ
        β-cells_JJ from_IN the_DT mouse_NN ,_, activation_NN of_IN PKC_NNP by_IN PMA_NNP did_VBD not_RB
        cause_VB any_DT change_NN in_IN membrane_NN potential_JJ [_NN 15_CD 16_CD ]_NN ,_, although_IN
        in_IN the_DT same_JJ cell_NN type_NN ,_, PMA_NNP reduced_VBD the_DT glucose-stimulated_JJ
        elevation_NN of_IN [_NN Ca_MD 2_CD +_NN ]_NN 
        i_NNP depending_VBG on_IN activation_NN of_IN PKC_NNP [_NN 16_CD ]_NN
        ._. On_IN the_DT other_JJ hand_NN ,_, recent_JJ studies_NNS in_IN myocytes_NNS suggest_VBP
        that_DT activation_NN of_IN PKC_NNP increases_VBZ the_DT open-time_JJ probability_NN
        of_IN K_NNP 
        ATP_NNP (_( SUR_NNP 2_CD ,_, Kir_NNP 6_CD ._. 1_LS )_) by_IN reducing_VBG the_DT
        sensitivity_NN of_IN K_NNP 
        ATP_NNP to_TO ATP_NNP [_NN 17_CD 18_CD 19_CD 20_CD ]_NN ._. Therefore_RB ,_,
        whether_IN regulation_NN of_IN insulin_NN secretion_NN by_IN PMA_NNP is_VBZ mediated_JJ
        through_IN PKC_NNP or_CC not_RB is_VBZ still_RB obscure_JJ ._. Recently_RB ,_, we_PRP reported_VBD
        that_DT phorbol_NN ester_NN inhibited_VBD Ca_MD 2_CD +_NN influx_NN through_IN
        PKC-dependent_NNP and_CC PKC-independent_NNP pathways_NNS [_NN 21_CD ]_NN ._. In_IN the_DT
        present_JJ study_NN ,_, we_PRP further_RBR evaluated_VBD the_DT non-_NN PKC_NNP mechanism_NN
        of_IN PMA_NNP action_NN on_IN β-cell_JJ electrical_JJ excitation_NN by_IN using_VBG
        patch-clamp_JJ techniques_NNS ._. The_DT results_NNS indicate_VBP that_IN in_IN rat_NN
        pancreatic_JJ β-cells_JJ ,_, PMA_NNP modulates_NNS insulin_NN secretion_NN through_IN
        a_DT mixed_JJ mechanism_NN :_: increases_NNS insulin_NN secretion_NN by_IN
        activation_NN of_IN PKC_NNP ,_, and_CC meanwhile_RB decrease_VB insulin_NN secretion_NN
        by_IN impairing_VBG β-cell_JJ excitability_NN in_IN a_DT PKC-independent_NNP
        manner_NN ._. The_DT enhancement_NN of_IN K_NNP 
        ATP_NNP activity_NN by_IN reducing_VBG sensitivity_NN of_IN
        K_NNP 
        ATP_NNP to_TO ATP_NNP seems_VBZ to_TO underlie_VB the_DT
        PMA-induced_NNP impairment_NN of_IN β-cells_JJ electrical_JJ excitation_NN in_IN
        response_NN to_TO glucose_NN stimulation_NN ._.
      
      
        Results_NNS
        
          PMA_NNP inhibits_NNS electrical_JJ excitation_NN of_IN single_JJ rat_NN
          β-cells_JJ
          With_IN glucose_NN at_IN 5_CD ._. 5_CD mM_NN in_IN the_DT extracellular_NN solution_NN ,_,
          the_DT membrane_NN potential_JJ ,_, measured_VBN using_VBG the_DT
          nystatin-perforation_JJ technique_NN ,_, was_VBD stable_JJ (_( -_: 52_CD ._. 9_CD ±_NN 1_CD ._. 1_CD
          mV_NN ,_, mean_VB ±_NN SE_NNP ,_, n_NN =_SYM 28_CD )_) ._. Bath-applied_NNP 15_CD mM_NN glucose_NN
          induced_VBD the_DT action_NN potential_JJ spikes_NNS superimposed_VBN on_IN a_DT
          slow_JJ membrane_NN depolarization_NN (_( Fig_NNP ._. 1_LS panel_NN A_DT )_) ._. When_WRB PMA_NNP
          (_( 80_CD nM_NN )_) was_VBD applied_VBN to_TO the_DT cell_NN during_IN 15_CD mM_NN glucose_NN
          stimulation_NN ,_, both_DT slow_JJ depolarization_NN and_CC action_NN
          potentials_NNS was_VBD abolished_VBN ._. The_DT effect_NN of_IN PMA_NNP was_VBD
          reversible_JJ after_IN removal_NN of_IN PMA_NNP (_( Fig_NNP ._. 1_LS panel_NN A_DT )_) ._. This_DT
          inhibitory_NN effect_NN by_IN PMA_NNP appeared_VBD to_TO be_VB independent_JJ of_IN
          PKC_NNP since_IN addition_NN of_IN the_DT PKC_NNP blocker_NN ,_, BIM_NNP (_( 1_CD μM_NN )_) did_VBD not_RB
          prevent_VB PMA-induced_NNP inhibition_NN (_( Fig_NNP ._. 1_LS panel_NN B_NNP )_) ._. In_IN two_CD
          experiments_NNS ,_, higher_JJR concentration_NN (_( 10_CD μM_NN )_) of_IN BIM_NNP failed_VBD
          to_TO prevent_VB PMA-induced_NNP inhibition_NN too_RB (_( data_NNS not_RB shown_VBN )_) ._.
          In_IN the_DT presence_NN of_IN 5_CD ._. 5_CD mM_NN glucose_NN ,_, 63_CD %_NN of_IN tested_VBN β-cells_JJ
          (_( 5_CD /_NN 8_CD )_) showed_VBD spontaneous_JJ action_NN potentials_NNS superimposed_VBN
          on_IN a_DT slow_JJ depolarizing_VBG potential_JJ ,_, and_CC PMA_NNP (_( 80_CD nM_NN )_)
          inhibited_VBD these_DT action_NN potentials_NNS as_RB well_RB (_( Fig_NNP ._. 1_LS panel_NN
          C_NNP )_) ._.
        
        
          PMA_NNP induces_VBZ hyperpolarization_NN of_IN rat_NN β-cells_JJ
          In_IN the_DT presence_NN of_IN 5_CD ._. 5_CD mM_NN glucose_NN ,_, application_NN of_IN PMA_NNP
          (_( 80_CD nM_NN )_) alone_RB induced_VBD a_DT slow_JJ ,_, reversible_JJ membrane_NN
          hyperpolarization_NN (_( Fig_NNP ._. 2_LS panel_NN A_DT )_) ._. The_DT magnitude_NN of_IN the_DT
          hyperpolarization_NN depended_VBD on_IN the_DT concentration_NN of_IN PMA_NNP
          (_( Fig_NNP ._. 2_LS panel_NN C_NNP )_) ._. Pretreatment_NNP of_IN cells_NNS with_IN the_DT PKC_NNP
          inhibitor_NN ,_, BIM_NNP (_( 1_CD μM_NN )_) for_IN about_IN 60_CD min_NN did_VBD not_RB prevent_VB
          PMA-induced_NNP hyperpolarization_NN (_( Fig_NNP ._. 2_LS panel_NN B_NNP )_) ._. Figure_NN
          2_CD Csummarized_NNP that_IN PMA-induced_NNP hyperpolarization_NN was_VBD not_RB
          significantly_RB different_JJ between_IN BIM-treated_NNP and_CC
          BIM-untreated_NNP β-cells_JJ (_( Fig_NNP ._. 2_LS panel_NN C_NNP )_) ._. These_DT results_NNS
          indicate_VBP that_IN PMA-induced_NNP hyperpolarization_NN of_IN pancreatic_JJ
          β-cells_JJ is_VBZ not_RB mediated_JJ through_IN PKC_NNP activation_NN ._.
        
        
          PMA_NNP increases_VBZ K_NNP ATPactivity_NNP in_IN cell-attached_JJ single_JJ
          channel_NN recording_NN
          Since_IN K_NNP 
          ATP_NNP plays_VBZ a_DT crucial_JJ role_NN in_IN
          glucose-stimulated_JJ insulin_NN secretion_NN ,_, PMA-induced_NNP
          hyperpolarization_NN could_MD be_VB mediated_JJ by_IN changes_NNS in_IN K_NNP 
          ATP_NNP activity_NN ._. To_TO test_VB this_DT hypothesis_NNS ,_,
          we_PRP examined_VBD the_DT effect_NN of_IN PMA_NNP on_IN single_JJ channel_NN
          activities_NNS of_IN K_NNP 
          ATP_NNP ._. In_IN the_DT cell-attached_JJ
          configuration_NN ,_, spontaneous_JJ single_JJ channel_NN currents_NNS were_VBD
          recorded_VBN at_IN a_DT pipette_NN potential_NN of_IN 0_CD mV_NN (_( Fig_NNP ._. 3_LS )_) ._. The_DT
          specific_JJ K_NNP 
          ATP_NNP blocker_NN ,_, tolbutamide_NN (_( 0_CD ._. 5_LS mM_NN )_)
          completely_RB inhibited_VBD channel_NN activity_NN (_( Fig_NNP ._. 3_LS )_) ,_,
          indicating_VBG that_IN the_DT recorded_VBN single_JJ channel_NN currents_NNS are_VBP
          passed_VBN through_IN K_NNP 
          ATP_NNP channels_NNS ._. Application_NNP of_IN 80_CD nM_NN PMA_NNP
          to_TO the_DT bath_NN solution_NN significantly_RB increased_VBD channel_NN
          activities_NNS (_( Fig_NNP ._. 3_LS )_) ._. Values_NNP of_IN open-time_JJ probability_NN for_IN
          K_NNP 
          ATP_NNP were_VBD 0_CD ._. 08_CD ±_NN 0_CD ._. 01_CD before_IN
          application_NN of_IN PMA_NNP and_CC 0_CD ._. 11_CD ±_NN 0_CD ._. 01_CD during_IN application_NN of_IN
          PMA_NNP (_( n_NN =_SYM 9_CD ,_, Mean_VB ±_NN SEM_NNP ,_, P_NN <_NN 0_CD ._. 01_CD )_) ._. This_DT result_NN
          indicates_VBZ that_IN PMA_NNP indeed_RB increases_VBZ K_NNP 
          ATP_NNP activity_NN ._.
        
        
          PMA_NNP increases_NNS whole-cell_JJ membrane_NN current_JJ through_IN K_NNP
          ATP_NNP
          In_IN the_DT whole-cell_JJ configuration_NN ,_, membrane_NN currents_NNS in_IN
          response_NN to_TO repeatedly_RB applied_VBN voltage_NN ramp_NN pulses_NNS from_IN
          -_: 90_CD to_TO -_: 50_CD mV_NN were_VBD recorded_VBN ._. Tolbutamide_NNP (_( 0_CD ._. 5_LS mM_NN )_)
          markedly_RB reduced_VBD the_DT size_NN of_IN the_DT current_NN ,_, and_CC after_IN
          blockade_NN of_IN membrane_NN current_JJ ,_, PMA_NNP failed_VBD to_TO increase_VB the_DT
          current_JJ (_( Fig_NNP ._. 4_LS panel_NN A_DT )_) ,_, suggesting_VBG that_IN PMA_NNP increased_VBD
          membrane_NN currents_NNS through_IN K_NNP 
          ATP_NNP ._. Application_NNP of_IN PMA_NNP (_( 80_CD nM_NN )_)
          increased_VBD the_DT magnitude_NN of_IN membrane_NN current_JJ (_( Fig_NNP ._. 4_LS panel_NN
          B_NNP )_) and_CC the_DT magnitude_NN of_IN increased_VBN currents_NNS depended_VBD on_IN
          the_DT concentrations_NNS of_IN PMA_NNP (_( Fig_NNP ._. 4_LS panel_NN D_NNP )_) ._. In_IN cells_NNS
          treated_VBN with_IN BIM_NNP (_( 1_CD μM_NN )_) ,_, PMA_NNP still_RB increased_VBD membrane_NN
          current_JJ (_( Fig_NNP ._. 4_LS panel_NN C_NNP )_) ._. No_DT significant_JJ differences_NNS were_VBD
          observed_VBN between_IN BIM-untreated_NNP and_CC treated_VBN cells_NNS for_IN
          PMA-induced_NNP membrane_NN current_JJ increase_NN (_( Fig_NNP ._. 4_LS panel_NN D_NNP )_) ,_,
          suggesting_VBG that_IN PMA_NNP increases_VBZ K_NNP 
          ATP_NNP -_: mediated_JJ currents_NNS in_IN a_DT
          PKC-independent_NNP manner_NN ._.
        
        
          4_LS α-_NN PDD_NNP mimics_VBZ the_DT effect_NN of_IN PMA_NNP on_IN electrical_JJ
          properties_NNS of_IN rat_NN β-cells_JJ
          There_EX are_VBP two_CD ways_NNS to_TO test_VB the_DT hypothesis_NNS that_IN the_DT
          effect_NN of_IN PMA_NNP on_IN electrical_JJ properties_NNS of_IN rat_NN β-cells_JJ is_VBZ
          independent_JJ of_IN PKC_NNP activation_NN ._. One_CD is_VBZ to_TO use_VB specific_JJ PKC_NNP
          blockers_NNS ,_, like_IN BIM_NNP ,_, to_TO examine_VB whether_IN the_DT effect_NN of_IN PMA_NNP
          can_MD be_VB prevented_VBN (_( Fig_NNP ._. 1_LS ,_, 2_CD ,_, 4_LS )_) ._. Another_DT way_NN is_VBZ to_TO employ_VB
          PMA_NNP analogs_NNS ,_, which_WDT do_VBP not_RB stimulate_VB PKC_NNP ,_, to_TO see_VB if_IN they_PRP
          can_MD mimic_VB the_DT PMA_NNP effect_NN ._. 4_LS α-_NN PDD_NNP ,_, as_IN a_DT PKC_NNP
          non-stimulating_JJ phorbol_NN ester_NN [_NN 22_CD ]_NN ,_, provides_VBZ a_DT good_JJ
          opportunity_NN to_TO test_VB our_PRP$ hypothesis_NNS ._. As_IN shown_VBN in_IN Fig_NNP ._.
          5_LS panel_NN A_DT ,_, 4_CD α-_NN PDD_NNP (_( 1_CD μM_NN )_) completely_RB abolished_VBN action_NN
          potentials_NNS elicited_JJ by_IN elevation_NN of_IN glucose_NN concentration_NN
          from_IN 5_CD ._. 5_CD to_TO 15_CD mM_NN ,_, just_RB like_IN the_DT PMA_NNP effect_NN in_IN Fig_NNP ._.
          1_LS panel_NN A_DT ._. In_IN voltage-clamp_JJ current_JJ recordings_NNS (_( Fig_NNP ._.
          5_LS panel_NN B_NNP )_) ,_, 4_CD α-_NN PDD_NNP (_( 1_CD μM_NN )_) increased_VBN membrane_NN current_JJ
          evoked_JJ by_IN ramp_NN from_IN -_: 90_CD to_TO -_: 50_CD mV_NN ,_, similar_JJ to_TO the_DT PMA_NNP
          effect_NN in_IN figure_NN 4_CD panel_NN B_NNP ._. The_DT similar_JJ results_NNS have_VBP also_RB
          been_VBN obtained_VBN by_IN low_JJ concentration_NN of_IN 4_CD α-_NN PDD_NNP (_( 80_CD nM_NN ,_, n_NN =_SYM
          3_CD for_IN current-clamp_JJ data_NNS and_CC n_NN =_SYM 2_CD for_IN voltage-clamp_JJ
          data_NNS ,_, data_NNS not_RB shown_VBN )_) ._. These_DT results_NNS indicate_VBP that_IN 4_CD α-_NN PDD_NNP
          virtually_RB mimics_VBZ PMA_NNP effects_NNS ,_, and_CC these_DT data_NNS further_JJ
          support_NN the_DT idea_NN that_IN the_DT increase_NN of_IN K_NNP 
          ATP_NNP activity_NN by_IN PMA_NNP does_VBZ not_RB depend_VB on_IN
          PKC_NNP activation_NN ._.
        
        
          Possible_JJ mechanism_NN of_IN PMA_NNP increases_VBZ K_NNP
          ATPactivity_NNP
          How_WRB does_VBZ PMA_NNP increase_NN K_NNP 
          ATP_NNP activity_NN ?_. Two_CD possible_JJ
          explanations_NNS might_MD be_VB addressed_VBN ._. First_LS ,_, PMA_NNP reduces_VBZ the_DT
          sensitivity_NN of_IN K_NNP 
          ATP_NNP to_TO ATP_NNP as_IN reports_NNS using_VBG myocytes_NNS [_NN
          17_CD 18_CD 19_CD 20_CD ]_NN ._. Second_JJ ,_, PMA_NNP may_MD reduce_VB ATP_NNP production_NN ._. To_TO
          assess_VB the_DT effects_NNS of_IN PMA_NNP on_IN K_NNP 
          ATP_NNP activity_NN ,_, we_PRP performed_VBD two_CD
          experiments_NNS ._. First_LS ,_, using_VBG inside-out_JJ recording_NN
          configuration_NN ,_, spontaneous_JJ single_JJ channel_NN activities_NNS were_VBD
          more_RBR prominent_JJ when_WRB there_EX was_VBD no_DT ATP_NNP in_IN bath_NN solution_NN
          (_( intracellular_NN face_NN )_) ,_, and_CC recorded_VBD currents_NNS were_VBD very_RB
          sensitive_JJ to_TO bath-applied_JJ tolbutamide_NN (_( 0_CD ._. 5_LS mM_NN ,_, Fig_NNP ._.
          6_CD panel_NN A_DT )_) ._. In_IN the_DT absence_NN of_IN ATP_NNP in_IN the_DT bath_NN ,_, application_NN
          of_IN PMA_NNP showed_VBD little_JJ effect_NN on_IN K_NNP 
          ATP_NNP activity_NN (_( Fig_NNP ._. 6_CD panel_NN B_NNP )_) ._. Values_NNP
          of_IN the_DT open-time_JJ probability_NN for_IN K_NNP 
          ATP_NNP were_VBD 0_CD ._. 19_CD ±_NN 0_CD ._. 02_CD (_( n_NN =_SYM 12_CD )_) without_IN
          and_CC 0_CD ._. 20_CD ±_NN 0_CD ._. 02_CD (_( n_NN =_SYM 5_LS )_) with_IN 80_CD nM_NN PMA_NNP (_( P_NN >_NN 0_CD ._. 05_CD )_) ._. The_DT
          average_JJ single_JJ channel_NN conductances_NNS were_VBD 68_CD pS_NN without_IN
          and_CC 66_CD pS_NN with_IN 80_CD nM_NN PMA_NNP ,_, measured_VBN between_IN -_: 90_CD to_TO 0_CD mV_NN
          (_( Fig_NNP ._. 6_CD panel_NN D_NNP )_) ._. Application_NNP of_IN 10_CD μM_NN ATP_NNP to_TO the_DT bath_NN
          decreased_VBD the_DT open_JJ probability_NN of_IN K_NNP 
          ATP_NNP ,_, and_CC under_IN this_DT condition_NN ,_, PMA_NNP
          restored_VBD K_NNP 
          ATP_NNP activity_NN (_( Fig_NNP ._. 6_CD panel_NN C_NNP )_) even_RB in_IN
          the_DT presence_NN of_IN 1_CD μM_NN BIM_NNP (_( Fig_NNP ._. 6_CD panel_NN E_NNP )_) ._. Values_NNP for_IN ATP_NNP
          concentration_NN producing_VBG half-maximal_JJ inhibition_NN of_IN K_NNP 
          ATP_NNP ,_, taken_VBN from_IN the_DT
          concentration-response_JJ relationships_NNS of_IN ATP_NNP inhibition_NN of_IN
          K_NNP 
          ATP_NNP activity_NN ,_, were_VBD 10_CD ._. 8_CD ±_NN 1_CD ._. 9_CD μM_NN (_( n_NN =_SYM
          6_CD )_) without_IN and_CC 24_CD ._. 9_CD ±_NN 4_CD ._. 9_CD μM_NN (_( n_NN =_SYM 5_LS )_) with_IN 80_CD nM_NN PMA_NNP (_( P_NN
          <_NN 0_CD ._. 05_CD ,_, Fig_NNP ._. 6_CD panel_NN F_NN )_) ._. Values_NNP of_IN the_DT Hill_NNP coefficient_NN
          were_VBD 1_CD ._. 04_CD ±_NN 0_CD ._. 02_CD without_IN and_CC 1_CD ._. 08_CD ±_NN 0_CD ._. 02_CD with_IN PMA_NNP (_( P_NN >_NN
          0_CD ._. 05_CD )_) ._. These_DT results_NNS indicate_VBP that_IN PMA_NNP increases_VBZ K_NNP 
          ATP_NNP activity_NN in_IN the_DT presence_NN of_IN
          intracellular_NN ATP_NNP ,_, which_WDT implies_VBZ that_IN PMA_NNP may_MD reduce_VB the_DT
          sensitivity_NN of_IN K_NNP 
          ATP_NNP to_TO ATP_NNP ._. Second_JJ ,_, the_DT ATP_NNP content_NN of_IN
          rat_NN islets_NNS was_VBD measured_VBN during_IN PMA_NNP treatment_NN ._. As_IN shown_VBN in_IN
          Table_NNP 1_CD ,_, 10_CD min_NN loading_NN of_IN islets_NNS with_IN extracellular_NN
          solution_NN containing_VBG 80_CD nM_NN PMA_NNP did_VBD not_RB alter_VB ATP_NNP content_NN
          of_IN islets_NNS ._. On_IN the_DT other_JJ hand_NN ,_, loading_NN cells_NNS with_IN 1_CD mM_NN
          NaCN_NNP markedly_RB reduced_VBD ATP_NNP content_NN ._.
        
        
          Effects_NNPS of_IN PMA_NNP on_IN glucose-induced_JJ insulin_NN
          secretion_NN
          The_DT results_NNS presented_VBD such_JJ far_RB indicate_VBP that_IN PMA_NNP
          decreases_NNS electrical_JJ excitation_NN of_IN β-cells_JJ and_CC this_DT
          effect_NN is_VBZ independent_JJ on_IN PKC_NNP activation_NN ._. According_VBG to_TO
          insulin_NN secretion_NN theory_NN ,_, decrease_NN of_IN electrical_JJ
          excitation_NN of_IN β-cells_JJ should_MD reduce_VB insulin_NN secretion_NN ._. To_TO
          address_VB this_DT question_NN ,_, we_PRP measured_VBD insulin_NN secretion_NN from_IN
          rat_NN islets_NNS ._. As_IN shown_VBN in_IN Fig_NNP ._. 7_CD ,_, PMA_NNP (_( 80_CD nM_NN )_) increase_NN both_DT
          basal_NN (_( 5_CD ._. 5_LS mM_NN glucose_NN in_IN the_DT extracellular_NN solution_NN )_) and_CC
          evoked_JJ (_( 16_CD ._. 6_CD mM_NN glucose_NN in_IN the_DT extracellular_NN solution_NN )_)
          insulin_NN secretion_NN rates_NNS ._. However_RB ,_, as_IN we_PRP expected_VBD ,_, in_IN
          BIM-treated_NNP islets_NNS PMA_NNP (_( 80_CD nM_NN )_) decreased_VBD the_DT rates_NNS of_IN
          insulin_NN secretion_NN (_( Fig_NNP ._. 7_CD )_) ._. These_DT data_NNS indicate_VBP that_IN PMA_NNP
          regulates_VBZ insulin_NN secretion_NN mediated_JJ by_IN a_DT mixed_JJ
          mechanism_NN ,_, a_DT PKC-dependent_NNP increase_NN of_IN insulin_NN secretion_NN
          and_CC a_DT PKC-independent_NNP decrease_NN of_IN insulin_NN secretion_NN ._.
        
      
      
        Discussion_NNP
        Phorbol_NNP esters_NNS are_VBP often_RB used_VBN as_IN activators_NNS of_IN PKC_NNP to_TO
        investigate_VB the_DT role_NN of_IN the_DT kinase_NN in_IN cellular_JJ functions_NNS [_NN
        1_CD ]_NN ._. Accumulating_NNP lines_NNS of_IN evidence_NN indicates_VBZ that_IN PMA_NNP
        plays_VBZ a_DT complex_JJ role_NN in_IN regulation_NN of_IN cellular_JJ function_NN ,_,
        including_VBG PKC-dependent_NNP [_NN 18_CD 19_CD 20_CD ]_NN and_CC PKC-independent_NNP
        ways_NNS [_NN 23_CD 24_CD 21_CD ]_NN ._. In_IN the_DT present_JJ results_NNS ,_, PMA_NNP inhibited_VBD
        slow_JJ membrane_NN depolarization_NN and_CC action_NN potentials_NNS in_IN
        response_NN to_TO glucose_NN stimulation_NN (_( Fig_NNP ._. 1_LS )_) ,_, and_CC caused_VBD a_DT
        membrane_NN hyperpolarization_NN in_IN rat_NN β-cells_JJ (_( Fig_NNP ._. 2_LS )_) ._. These_DT
        findings_NNS are_VBP consistent_JJ with_IN the_DT observation_NN that_IN
        12_CD -_: O-_NNP tetradecanoylphorbol_NN 13_CD -_: acetate_NN lowers_VBZ [_NN Ca_MD 2_CD +_NN ]_NN 
        i_NNP at_IN a_DT stimulatory_NN glucose_NN concentration_NN
        in_IN pancreatic_JJ islets_NNS from_IN obese-hyperglycaemic_JJ mice_NNS [_NN 16_CD ]_NN
        ._. Since_IN PMA_NNP increased_VBD K_NNP 
        ATP_NNP activity_NN (_( Fig_NNP ._. 3_LS )_) ,_, it_PRP is_VBZ obvious_JJ
        that_IN the_DT hyperpolarization_NN caused_VBN by_IN PMA_NNP results_NNS from_IN
        activation_NN of_IN this_DT channel_NN type_NN ,_, and_CC PMA_NNP inhibition_NN of_IN
        glucose-induced_JJ electrical_JJ excitation_NN of_IN rat_NN β-cells_JJ is_VBZ
        ascribable_JJ at_IN least_JJS in_IN part_NN to_TO hyperpolarization_NN resulting_VBG
        from_IN an_DT increase_NN in_IN K_NNP 
        ATP_NNP activity_NN ._. The_DT activity_NN of_IN K_NNP 
        ATP_NNP can_MD be_VB regulated_VBN by_IN changes_NNS in_IN
        intracellular_NN concentration_NN of_IN ATP_NNP and_CC /_NN or_CC ATP_NNP /_NN ADP_NNP ratio_NN [_NN 9_CD
        ]_NN ._. In_IN order_NN to_TO examine_VB whether_IN PMA_NNP decrease_VB β-cell_JJ ATP_NNP
        concentration_NN ,_, we_PRP measured_VBD ATP_NNP content_NN of_IN rat_NN islets_NNS ,_, and_CC
        results_NNS indicated_VBD that_IN PMA_NNP did_VBD not_RB change_VB ATP_NNP levels_NNS in_IN
        islets_NNS (_( Table_NNP 1_LS )_) ._. It_PRP is_VBZ not_RB clear_JJ at_IN present_JJ whether_IN ADP_NNP
        concentrations_NNS are_VBP changed_VBN by_IN the_DT phorbol_NN ester_NN ._. Under_IN a_DT
        condition_NN where_WRB ATP_NNP concentration_NN in_IN the_DT β-cell_JJ was_VBD clamped_VBN
        at_IN a_DT constant_JJ level_NN ,_, PMA_NNP increased_VBD tolbutamide-sensitive_JJ
        currents_NNS in_IN response_NN to_TO voltage_NN ramps_NNS from_IN -_: 90_CD to_TO -_: 50_CD mV_NN
        (_( Fig_NNP ._. 4_LS )_) ._. Furthermore_RB ,_, in_IN inside-out_JJ single_JJ channel_NN
        recordings_NNS ,_, PMA_NNP restored_VBD K_NNP 
        ATP_NNP activity_NN ,_, which_WDT had_VBD been_VBN reduced_VBN by_IN
        the_DT preceding_VBG application_NN of_IN ATP_NNP (_( Figs_NNP ._. 6_CD panels_NNS C_NNP ,_, E_NNP )_) ._.
        Together_RB ,_, these_DT findings_NNS support_VBP the_DT idea_NN that_IN PMA_NNP
        activation_NN of_IN K_NNP 
        ATP_NNP does_VBZ not_RB result_VB from_IN a_DT change_NN in_IN ATP_NNP
        concentration_NN ._.
        In_IN cardiac_JJ myocytes_NNS ,_, PMA_NNP is_VBZ known_VBN to_TO activate_VBP K_NNP 
        ATP_NNP through_IN activation_NN of_IN PKC_NNP [_NN 18_CD 19_CD 20_CD
        ]_NN ._. In_IN insulin-secreting_JJ cell_NN lines_NNS as_IN well_RB ,_, PKC_NNP activation_NN
        by_IN PMA_NNP was_VBD shown_VBN to_TO potentiate_NN K_NNP 
        ATP_NNP activity_NN [_NN 11_CD 12_CD ]_NN ._. In_IN the_DT present_JJ
        study_NN ,_, however_RB ,_, the_DT activation_NN of_IN K_NNP 
        ATP_NNP activity_NN by_IN PMA_NNP is_VBZ independent_JJ on_IN
        activation_NN of_IN PKC_NNP for_IN two_CD reasons_NNS ._. First_LS ,_, the_DT PKC_NNP
        activation_NN inhibitor_NN ,_, BIM_NNP ,_, did_VBD not_RB prevent_VB either_CC the_DT
        PMA-induced_NNP hyperpolarization_NN (_( Figs_NNP ._. 2_LS panels_NNS B_NNP &_CC C_NNP )_) or_CC
        augmentation_NN of_IN whole-cell_JJ membrane_NN currents_NNS (_( Fig_NNP ._. 4_LS panels_NNS
        C_NNP &_CC D_NNP )_) ._. Second_JJ ,_, the_DT non-_NN PKC-stimulating_NNP phorbol_NN ester_NN ,_,
        4_CD α-_NN PDD_NNP ,_, mimicked_JJ the_DT effect_NN of_IN PMA_NNP (_( Fig_NNP ._. 5_LS panel_NN C_NNP )_) ._.
        Pharmacological_NNP effects_NNS of_IN PMA_NNP independent_JJ of_IN activation_NN
        of_IN PKC_NNP have_VBP been_VBN demonstrated_VBN in_IN various_JJ tissues_NNS [_NN 23_CD 24_CD ]_NN
        ._. Since_IN the_DT magnitude_NN of_IN hyperpolarization_NN induced_VBN by_IN PMA_NNP
        (_( Fig_NNP ._. 2_LS panel_NN C_NNP )_) and_CC the_DT effects_NNS of_IN PMA_NNP on_IN K_NNP 
        ATP_NNP activity_NN (_( Fig_NNP ._. 6_CD panel_NN E_NNP )_) were_VBD not_RB
        significantly_RB different_JJ between_IN cells_NNS treated_VBN or_CC untreated_JJ
        with_IN BIM_NNP ,_, activation_NN of_IN PKC_NNP seems_VBZ to_TO show_VB little_JJ effect_NN on_IN
        K_NNP 
        ATP_NNP ,_, at_IN least_JJS in_IN this_DT cell_NN type_NN ._. In_IN
        this_DT regard_NN ,_, the_DT present_JJ findings_NNS support_VBP the_DT idea_NN derived_VBN
        from_IN previous_JJ findings_NNS on_IN mouse_NN [_NN 15_CD ]_NN or_CC
        obese-hyperglycaemic_JJ mouse_NN β-cells_JJ [_NN 16_CD ]_NN ._. However_RB ,_,
        PMA-induced_NNP PKC-independent_NNP hyperpolarization_NN of_IN β-cells_JJ
        was_VBD not_RB previously_RB reported_VBD [_NN 15_CD 16_CD ]_NN ._. The_DT reason_NN for_IN the_DT
        discrepancy_NN is_VBZ not_RB clear_JJ at_IN the_DT moment_NN ._. The_DT difference_NN in_IN
        species_NNS (_( rat_NN in_IN the_DT present_JJ study_NN and_CC mouse_NN in_IN previous_JJ
        studies_NNS )_) could_MD be_VB one_CD explanation_NN ._. In_IN addition_NN ,_,
        hyperpolarization_NN in_IN response_NN to_TO PMA_NNP might_MD be_VB unnoticed_JJ
        under_IN some_DT conditions_NNS with_IN intracellular_NN ATP_NNP at_IN particular_JJ
        concentrations_NNS ,_, because_RB ,_, as_IN shown_VBN in_IN Fig_NNP ._. 6_CD panel_NN F_NN ,_, the_DT
        effect_NN of_IN PMA_NNP on_IN K_NNP 
        ATP_NNP activity_NN ,_, which_WDT produces_VBZ
        hyperpolarization_NN ,_, varied_VBD as_IN a_DT function_NN of_IN intracellular_NN
        ATP_NNP concentration_NN ._.
        There_EX are_VBP two_CD possible_JJ explanations_NNS for_IN the_DT
        PKC-independent_NNP activation_NN of_IN K_NNP 
        ATP_NNP by_IN phorbol_NN esters_NNS :_: 1_LS )_) phorbol_NN esters_NNS
        may_MD increase_VB K_NNP 
        ATP_NNP activity_NN in_IN an_DT intracellular_NN
        ATP-independent_NNP manner_NN and_CC 2_LS )_) phorbol_NN esters_NNS may_MD reduce_VB
        sensitivity_NN of_IN K_NNP 
        ATP_NNP to_TO ATP_NNP ._. The_DT first_JJ possibility_NN can_MD be_VB
        discounted_VBN because_IN PMA_NNP does_VBZ not_RB affect_VB K_NNP 
        ATP_NNP activity_NN in_IN the_DT absence_NN of_IN ATP_NNP (_( Fig_NNP ._.
        6_CD panel_NN B_NNP )_) ._. On_IN the_DT other_JJ hand_NN ,_, PMA_NNP restoration_NN of_IN K_NNP 
        ATP_NNP activity_NN which_WDT had_VBD been_VBN reduced_VBN by_IN
        ATP_NNP (_( Fig_NNP ._. 6_CD panels_NNS C_NNP ,_, E_NNP )_) supports_VBZ the_DT conclusion_NN that_IN
        phorbol_NN esters_NNS decrease_VBP K_NNP 
        ATP_NNP sensitivity_NN to_TO ATP_NNP ._.
        In_IN the_DT present_JJ study_NN ,_, application_NN of_IN PMA_NNP potentiated_JJ
        insulin_NN secretion_NN from_IN rat_NN islets_NNS in_IN response_NN to_TO elevation_NN
        of_IN extracellular_NN glucose_NN concentration_NN (_( Fig_NNP ._. 7_CD )_) ,_, supporting_VBG
        the_DT hypothesis_NNS that_WDT activation_NN of_IN PKC_NNP synergizes_NNS secretory_NN
        process_NN activated_VBN by_IN the_DT glucose_NN stimulation_NN [_NN 3_CD 4_CD 5_CD ]_NN ._.
        BIM_NNP is_VBZ known_VBN to_TO selectively_RB inhibit_VB α_NN and_CC β_NN PKC_NNP isotypes_NNS [_NN
        25_CD ]_NN ,_, and_CC rat_VB pancreatic_JJ β-cells_JJ possess_VBP at_IN least_JJS one_CD PKC_NNP
        isotype_NN [_NN 2_CD ]_NN ._. In_IN fact_NN ,_, in_IN this_DT study_NN ,_, the_DT treatment_NN of_IN
        islets_NNS with_IN BIM_NNP reversed_VBD the_DT PMA_NNP effect_NN on_IN insulin_NN
        secretion_NN (_( Fig_NNP ._. 7_CD )_) ._. Therefore_RB ,_, BIM_NNP can_MD be_VB used_VBN as_IN a_DT PKC_NNP
        inhibitor_NN in_IN rat_NN pancreatic_JJ β-cells_JJ ,_, as_RB already_RB shown_VBN in_IN
        other_JJ tissues_NNS including_VBG murine_NN macrophages_NNS [_NN 26_CD ]_NN ,_, rat_NN
        adrenal_NN cortex_NN [_NN 27_CD ]_NN ,_, human_JJ melanocytes_NNS [_NN 28_CD ]_NN and_CC rabbit_NN
        vetricular_NN myocytes_NNS [_NN 20_CD ]_NN ._.
        Recent_JJ reports_NNS with_IN a_DT truncated_JJ isoform_NN of_IN Kir_NNP 6_CD ._. 2_LS have_VBP
        revealed_VBN that_IN an_DT ATP-inhibitory_NNP site_NN lies_VBZ on_IN the_DT Kir_NNP 6_CD ._. 2_LS
        subunit_NN [_NN 29_CD 30_CD ]_NN ._. In_IN addition_NN ,_, mutations_NNS of_IN the_DT
        C-_NNP terminus_JJ of_IN Kir_NNP 6_CD ._. 2_LS showed_VBD that_IN the_DT amino_JJ acid_NN sequence_NN of_IN
        the_DT C-_NNP terminus_JJ was_VBD responsible_JJ for_IN regulation_NN of_IN ATP_NNP
        sensitivity_NN to_TO K_NNP 
        ATP_NNP [_NN 31_CD ]_NN ._. It_PRP is_VBZ not_RB clear_JJ at_IN present_JJ
        whether_IN phorbol_NN ester_NN effects_NNS reflection_NN at_IN the_DT C-_NNP terminus_JJ ._.
        In_IN addition_NN ,_, other_JJ recent_JJ studies_NNS have_VBP shown_VBN that_IN the_DT
        membrane_NN phospholipid_NN
        phosohatidylinositol-_NN 4_CD ,_, 5_CD -_: bis-phosphate_JJ (_( PIP_NNP 
        2_LS )_) reduces_VBZ sensitivity_NN of_IN K_NNP 
        ATP_NNP to_TO ATP_NNP ,_, and_CC therefore_RB ,_, activates_NNS K_NNP 
        ATP_NNP [_NN 32_CD 33_CD 34_CD ]_NN ._. To_TO our_PRP$ knowledge_NN ,_,
        this_DT is_VBZ the_DT first_JJ report_NN of_IN regulation_NN of_IN K_NNP 
        ATP_NNP activity_NN by_IN phorbol_NN ester_NN in_IN rat_NN
        β-cells_JJ ._. The_DT present_JJ findings_NNS provide_VBP new_JJ insight_NN into_IN
        mechanisms_NNS of_IN PMA_NNP regulation_NN of_IN insulin_NN secretion_NN by_IN
        PMA_NNP ._.
      
      
        Conclusion_NNP
        The_DT major_JJ and_CC important_JJ finding_NN in_IN this_DT study_NN is_VBZ that_IN
        PMA_NNP impairs_NNS electrical_JJ excitation_NN of_IN rat_NN pancreatic_JJ β-cells_JJ
        through_IN PKC-independent_NNP mechanism_NN ._. PMA_NNP increases_VBZ K_NNP 
        ATP_NNP activity_NN ,_, induces_VBZ a_DT membrane_NN
        hyperpolarization_NN ,_, then_RB reduces_VBZ the_DT electrical_JJ excitability_NN
        of_IN pancreatic_JJ β-cells_JJ ,_, leading_VBG to_TO a_DT decrease_NN of_IN insulin_NN
        secretion_NN ._. Reduction_NNP of_IN sensitivity_NN of_IN K_NNP 
        ATP_NNP to_TO ATP_NNP seems_VBZ to_TO underlie_VB the_DT
        PMA-induced_NNP impairment_NN of_IN β-cells_JJ electrical_JJ excitation_NN in_IN
        response_NN to_TO glucose_NN stimulation_NN ._. These_DT results_NNS provide_VBP a_DT
        novel_NN insight_NN of_IN modulation_NN mechanism_NN of_IN insulin_NN secretion_NN
        by_IN PMA_NNP ,_, increases_VBZ insulin_NN secretion_NN by_IN activation_NN of_IN PKC_NNP ,_,
        and_CC meanwhile_RB decrease_VB insulin_NN secretion_NN by_IN impairing_VBG
        β-cell_JJ excitability_NN in_IN a_DT PKC-independent_NNP manner_NN in_IN rat_NN
        pancreatic_JJ β-cells_JJ ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Islet_NNP preparation_NN and_CC β-cell_JJ isolation_NN
          Isolation_NNP of_IN rat_NN islets_NNS was_VBD performed_VBN as_RB previously_RB
          described_VBD [_NN 35_CD 36_CD ]_NN ._. In_IN short_JJ ,_, male_JJ adult_NN rats_NNS (_( Wistar_NNP )_)
          were_VBD anesthetized_JJ with_IN diethyl_NN ether_NN ,_, and_CC 10_CD ml_NN Hank_NNP 's_POS
          buffered_JJ saline_NN (_( HBSS_NNP )_) containing_VBG collagenase_NN (_( 200_CD U_NNP /_NN ml_NN ,_,
          Wako_NNP Chem_NNP ._. ,_, Japan_NNP )_) was_VBD injected_VBN into_IN the_DT common_JJ bile_NN
          duct_NN ._. The_DT pancreas_NN swollen_JJ with_IN digestion_NN solution_NN was_VBD
          quickly_RB excised_VBN and_CC incubated_JJ in_IN a_DT plastic_NN culture_NN bottle_NN
          for_IN 20_CD min_NN at_IN 37_CD °_NN C_NNP ._. The_DT suspension_NN obtained_VBN by_IN shaking_VBG
          the_DT bottle_NN was_VBD filtered_VBN through_IN 0_CD ._. 5_CD mm_NN metal_NN mesh_NN and_CC
          washed_VBN with_IN HBSS_NNP including_VBG 2_CD %_NN bovine_JJ serum_NN albumin_NN (_( BSA_NNP )_) ._.
          About_IN 100_CD islets_NNS were_VBD obtained_VBN from_IN one_CD rat_NN with_IN the_DT
          histopaque_NN (_( specific_JJ gravity_NN 1_CD ._. 077_CD ,_, Sigma_NNP ,_, USA_NNP )_) gradient_NN
          method_NN ._. After_IN washing_VBG with_IN HBSS_NNP containing_VBG 2_CD %_NN BSA_NNP ,_, islets_NNS
          were_VBD cultured_JJ for_IN 24_CD hours_NNS with_IN 5_CD %_NN C_NNP 02_CD in_IN the_DT tissue_NN
          culture_NN medium_NN ._. Separation_NNP of_IN islets_NNS was_VBD carried_VBN out_IN
          using_VBG dispase_NN (_( 1000_CD U_NNP /_NN ml_NN ,_, Godo_NNP Shusei_NNP ,_, Japan_NNP )_) as_RB
          previously_RB described_VBD [_NN 35_CD ]_NN ._. Separated_NNP cells_NNS were_VBD again_RB
          cultured_JJ for_IN 1_CD -_: 4_CD days_NNS ._. Only_RB single_JJ cells_NNS were_VBD chosen_VBN for_IN
          experiments_NNS ._. β-cells_JJ were_VBD identified_VBN by_IN detecting_VBG the_DT
          responses_NNS of_IN the_DT cells_NNS to_TO 15_CD mM_NN glucose_NN or_CC 0_CD ._. 5_CD mM_NN
          tolbutamide_NN (_( Sigma_NNP ,_, USA_NNP )_) ._.
        
        
          Patch-clamp_NNP recordings_NNS
          Cells_NNP were_VBD kept_VBN in_IN a_DT 35_CD -_: mm_NN Petri_NNP dish_NN ,_, and_CC the_DT dish_NN
          was_VBD placed_VBN on_IN the_DT stage_NN of_IN an_DT inverted_JJ microscope_NN (_( IMT-_NNP 2_CD ,_,
          Olympus_NNP ,_, Tokyo_NNP ,_, Japan_NNP )_) ._. Membrane_NNP potentials_NNS and_CC membrane_NN
          currents_NNS were_VBD measured_VBN using_VBG a_DT patch-clamp_JJ amplifier_NN
          (_( EPC-_NNP 7_CD ,_, List_NN Electronic_NNP ,_, Darmstadt_NNP ,_, Germany_NNP )_) ._. The_DT
          nystatin-perforation_JJ method_NN [_NN 37_CD ]_NN was_VBD used_VBN to_TO measure_VB
          the_DT membrane_NN potential_JJ ,_, and_CC the_DT standard_JJ method_NN was_VBD used_VBN
          to_TO measure_VB whole-cell_JJ currents_NNS [_NN 38_CD ]_NN ._. The_DT resistance_NN of_IN
          the_DT electrode_NN ,_, filled_VBN with_IN the_DT pipette_NN solution_NN ,_, ranged_VBD
          from_IN 2_CD to_TO 4_CD MΩ_NNP ._. To_TO measure_VB the_DT whole-cell_JJ membrane_NN
          current_JJ ,_, voltage_NN ramp_NN pulses_NNS from_IN -_: 90_CD to_TO -_: 50_CD mV_NN were_VBD
          repeatedly_RB applied_VBN using_VBG a_DT ramp_NN pulse_NN generator_NN
          (_( SET-_NNP 2100_CD ,_, Nihon_NNP Kohden_NNP ,_, Tokyo_NNP ,_, Japan_NNP )_) ._. The_DT membrane_NN
          capacitance_NN ranged_VBD from_IN 8_CD to_TO 14_CD pF_NN ._. Series_NN resistances_NNS
          below_IN 12_CD MΩ_NNP were_VBD accepted_VBN ._. Single_NNP channel_NN current_JJ
          recordings_NNS were_VBD carried_VBN out_IN by_IN the_DT cell-attached_JJ and_CC
          inside-out_JJ configurations_NNS ._. All_DT electrophysiological_JJ
          experiments_NNS were_VBD carried_VBN out_RB at_IN room_NN temperature_NN ._. Data_NNS of_IN
          single_JJ channel_NN currents_NNS were_VBD low-pass_JJ filtered_VBN at_IN 1_CD KHz_NNP ,_,
          digitized_JJ at_IN 10_CD KHz_NNP and_CC analyzed_VBD using_VBG a_DT single_JJ channel_NN
          current_JJ analysis_NN program_NN (_( QP-_NNP 120_CD J_NNP ,_, Nihon_NNP Kohden_NNP )_) ._. The_DT
          open_JJ time_NN probability_NN (_( Po_NNP )_) of_IN the_DT single_JJ channel_NN was_VBD
          calculated_VBN according_VBG to_TO the_DT equation_NN Po_NNP =_SYM 1_CD -_: Pc_NNP 1_CD /_NN N_NNP where_WRB
          pc_NN is_VBZ the_DT total_NN closed_JJ time_NN probability_NN and_CC N_NNP is_VBZ the_DT
          total_JJ number_NN of_IN channels_NNS ._. The_DT Po_NNP for_IN K_NNP 
          ATP_NNP was_VBD shown_VBN as_IN function_NN of_IN the_DT
          concentration_NN of_IN ATP_NNP ._. Theoretical_NNP curves_NNS for_IN ATP_NNP
          inhibition_NN of_IN K_NNP 
          ATP_NNP activity_NN were_VBD fitted_JJ to_TO the_DT Hill_NNP
          equation_NN (_( P_NN /_NN Po_NNP )_) =_SYM l_NN /_NN {_( 1_CD +_NN (_( [_NN ATP_NNP ]_NN /_NN ki_NN )_) h_NN }_) where_WRB P_NN is_VBZ the_DT open_JJ
          time_NN probability_NN with_IN ATP_NNP at_IN each_DT concentration_NN ,_, Po_NNP is_VBZ
          the_DT open_JJ time_NN probability_NN without_IN ATP_NNP ,_, [_NN ATP_NNP ]_NN is_VBZ the_DT
          concentration_NN of_IN ATP_NNP ,_, ki_NN is_VBZ the_DT ATP_NNP concentration_NN at_IN
          which_WDT the_DT inhibition_NN is_VBZ half_JJ maximal_NN ,_, and_CC h_NN is_VBZ the_DT Hill_NNP
          coefficient_NN ._.
        
        
          Measurement_NNP of_IN ATP_NNP content_NN
          The_DT ATP_NNP concentration_NN of_IN islets_NNS was_VBD measured_VBN by_IN the_DT
          luciferin-luciferase_JJ method_NN [_NN 39_CD ]_NN ._. Assay_NNP kits_NNS (_( FL-ASC_NNP )_)
          were_VBD purchased_VBN from_IN Sigma_NNP ._. For_IN ATP_NNP assay_NN ,_, 500_CD isolated_VBN
          rat_NN pancreatic_JJ islets_NNS were_VBD suspended_VBN in_IN 1_CD ._. 2_CD ml_NN standard_JJ
          extracellular_NN solution_NN ._. After_IN application_NN of_IN PMA_NNP at_IN the_DT
          final_JJ concentration_NN of_IN 80_CD nM_NN ,_, islet_NN suspensions_NNS
          containing_VBG 17_CD islets_NNS were_VBD transferred_VBN to_TO reaction_NN tubes_NNS ,_,
          and_CC the_DT amount_NN of_IN emission_NN was_VBD immediately_RB measured_VBN using_VBG
          a_DT luminescence_NN reader_NN (_( BLR-_NNP 301_CD ,_, Aloka_NNP ,_, Japan_NNP )_) ._.
          Bioluminescence_NNP produced_VBN by_IN the_DT luciferin-luciferase_JJ
          reaction_NN was_VBD amplified_VBN and_CC output_NN as_IN the_DT count_NN rate_NN (_( cpm_NN )_)
          after_IN converting_VBG pulse_NN signals_NNS ._. Using_VBG a_DT calibration_NN
          curve_NN ,_, values_NNS of_IN counting_VBG rate_NN were_VBD calculated_VBN in_IN terms_NNS
          of_IN moles_NNS of_IN ATP_NNP ._.
        
        
          Measurement_NNP of_IN insulin_NN secretion_NN
          Isolated_NNP islets_NNS were_VBD hand-picked_JJ under_IN microscopy_NN ,_, and_CC
          ten_CD islets_NNS were_VBD distributed_VBN to_TO each_DT 35_CD -_: mm_NN Petri_NNP dish_NN with_IN
          3_CD ml_NN of_IN HBSS_NNP containing_VBG 5_CD ._. 5_CD mM_NN glucose_NN ,_, 20_CD mM_NN HEPES_NNP ,_, and_CC
          2_CD %_NN BSA_NNP ._. After_IN pre-incubation_JJ for_IN 60_CD min_NN ,_, islets_NNS were_VBD
          exposed_VBN to_TO 1_CD μM_NN BIM_NNP for_IN 60_CD min_NN ,_, and_CC then_RB measured_VBN insulin_NN
          secretion_NN rate_NN ._. The_DT PMA_NNP effects_NNS with_IN or_CC without_IN BIM_NNP on_IN
          insulin_NN secretion_NN were_VBD measured_VBN by_IN using_VBG immuno-reactive_JJ
          insulin_NN (_( IRI_NNP )_) and_CC stored_VBD at_IN -_: 20_CD °_NN C_NNP until_IN the_DT assay_NN ._. IRI_NNP
          was_VBD measured_VBN by_IN RIA_NNP using_VBG anti-human_JJ insulin_NN antibody_NN
          with_IN rat_NN insulin_NN standard_JJ (_( Radio-immunoassay_NNP Kit_NNP ,_, Insulin_NNP
          "_'' Eiken_NNP "_'' ,_, Tokyo_NNP Japan_NNP )_) ._.
        
        
          Solutions_NNPS and_CC Drugs_NNS
          The_DT standard_JJ extracellular_NN solution_NN contained_VBD 135_CD mM_NN
          NaCl_NNP ,_, 5_CD ._. 6_CD mM_NN KCl_NNP ,_, 1_CD ._. 2_CD mM_NN MgCl_NNP 2_CD ,_, 1_CD mM_NN CaCl_NNP 2_CD ,_, 5_CD mM_NN glucose_NN
          and_CC 10_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 3_CD ._. For_IN membrane_NN potential_JJ
          recordings_NNS ,_, the_DT pipette_NN solution_NN contained_VBD 100_CD mM_NN
          K-_NNP gluconate_NN ,_, 35_CD mM_NN KCl_NNP ,_, 5_CD mM_NN glucose_NN ,_, 0_CD ._. 5_CD mM_NN EGTA_NNP ,_, 10_CD mM_NN
          HEPES_NNP and_CC 200_CD mg_NN /_NN ml_NN nystatin_NN (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP ,_, USA_NNP )_) ,_,
          pH_NN 7_CD ._. 2_CD ._. For_IN whole-cell_JJ recordings_NNS ,_, the_DT pipette_NN solution_NN
          contained_VBD 100_CD mM_NN K-_NNP gluconate_NN ,_, 35_CD mM_NN KCl_NNP ,_, 1_CD ._. 2_CD mM_NN MgCl_NNP 
          2_CD ,_, 5_CD mM_NN glucose_NN ,_, 0_CD ._. 5_CD mM_NN EGTA_NNP ,_, 10_CD mM_NN
          HEPES_NNP ,_, pH_NN 7_CD ._. 2_CD ._. For_IN cell-attached_JJ and_CC inside-out_JJ single_JJ
          channel_NN recordings_NNS ,_, the_DT pipette_NN solution_NN contained_VBD 135_CD mM_NN
          KCl_NNP ,_, 1_CD ._. 2_CD mM_NN MgCl_NNP 
          2_CD ,_, 5_CD mM_NN glucose_NN ,_, 0_CD ._. 5_CD mM_NN EGTA_NNP and_CC 10_CD
          mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 3_CD ._. The_DT ionic_JJ composition_NN of_IN the_DT solution_NN
          inside_IN the_DT membrane_NN (_( bath_NN solution_NN )_) in_IN inside-out_JJ
          recordings_NNS was_VBD the_DT same_JJ as_IN that_DT of_IN the_DT pipette_NN solution_NN ,_,
          but_CC the_DT pH_NN of_IN this_DT solution_NN was_VBD 7_CD ._. 2_CD ._. In_IN inside-out_JJ
          recordings_NNS ,_, ATP_NNP was_VBD added_VBN to_TO the_DT bath_NN solution_NN at_IN various_JJ
          concentrations_NNS ._. Phorbol_NNP 12_CD -_: myristate_NN 13_CD -_: acetate_NN (_( PMA_NNP )_) ,_,
          4_CD a-phorbol_JJ 12_CD ,_, 13_CD -_: didecanoate_NN (_( 4_CD a-_NN PDD_NNP )_) ,_,
          bisindolylmaleimide_NN (_( BIM_NNP )_) and_CC NaCN_NNP were_VBD purchased_VBN from_IN
          Sigma_NNP ._. PMA_NNP and_CC 4_CD a-_NN PDD_NNP were_VBD dissolved_VBN in_IN ethanol_NN ,_, and_CC the_DT
          final_JJ concentration_NN of_IN ethanol_NN in_IN the_DT experimental_JJ
          solution_NN was_VBD less_JJR than_IN 0_CD ._. 01_CD %_NN ._. BIM_NNP was_VBD dissolved_VBN in_IN DMSO_NNP ,_,
          and_CC the_DT final_JJ concentration_NN of_IN DMSO_NNP in_IN the_DT experimental_JJ
          solution_NN was_VBD 0_CD ._. 1_CD %_NN ._. Cells_NNP in_IN the_DT experimental_JJ bath_NN were_VBD
          continuously_RB exposed_VBN to_TO a_DT stream_NN of_IN the_DT extracellular_NN
          solution_NN throughout_IN the_DT experiment_NN ._. In_IN the_DT use_NN of_IN BIM_NNP ,_,
          islets_NNS or_CC cells_NNS were_VBD preincubated_JJ in_IN the_DT solution_NN
          containing_VBG BIM_NNP (_( 50_CD μM_NN )_) for_IN 30_CD -_: 60_CD min_NN ,_, and_CC BIM_NNP was_VBD present_JJ
          in_IN the_DT bath_NN solution_NN throughout_IN the_DT experiment_NN
        
        
          Statistics_NNS
          Data_NNP were_VBD expressed_VBN as_IN mean_NN ±_NN SE_NNP of_IN several_JJ
          experiments_NNS ,_, and_CC statistical_JJ significance_NN was_VBD evaluated_VBN
          by_IN the_DT two-tail_JJ paired_VBN and_CC unpaired_JJ Student_NNP 's_POS t-tests_JJ ._. A_DT
          value_NN of_IN P_NN less_JJR than_IN 0_CD ._. 05_CD was_VBD accepted_VBN as_IN
          significant_JJ ._.
          This_DT study_NN was_VBD carried_VBN out_IN in_IN accordance_NN with_IN the_DT
          Guidelines_NNS for_IN Animal_NNP Experimentation_NNP ,_, Hirosaki_NNP
          University_NNP ,_, Japan_NNP ._.
        
      
      
        List_NN of_IN abbreviations_NNS
        phorbol_NN 12_CD -_: myristate_NN 13_CD -_: acetate_NN (_( PMA_NNP )_) ,_, protein_NN kinase_NN C_NNP
        (_( PKC_NNP )_) ,_, ATP-sensitive_NNP K_NNP +_NN channel_NN (_( K_NNP 
        ATP_NNP )_) ,_, 4_CD a-phorbol_JJ 12_CD ,_, 13_CD -_: didecanoate_NN
        (_( 4_CD a-_NN PDD_NNP )_) ,_, bisindolylmaleimide_NN (_( BIM_NNP )_) ._.
      
    
  
